Skip to main content

Vaccinex (Rochester), L.L.C.

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Vaccinex (Rochester), L.L.C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 5, 2023 (view filing)4:31 PM ETOct 32 daysZauderer Maurice and 1 otherPresident and CEOPPurchase+500.0K$1.00+$500.0K+104.3%979.6K after
Oct 5, 2023 (view filing)4:31 PM ETOct 3-42 daysZauderer Maurice and 1 otherPresident and CEOPPurchase+10.0K$0.9515+$9.52K+82.5%22.1K after2 lots
Oct 5, 2023 (view filing)4:31 PM ETOct 32 daysZauderer Maurice and 1 otherPresident and CEOPPurchase+500.0K$1.00+$500.0K–500.0K afterDerivative